209 related articles for article (PubMed ID: 3874793)
21. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens.
Thompson R; Seargeant L; Winter JS
J Pediatr; 1989 Mar; 114(3):400-4. PubMed ID: 2784166
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of 21-hydroxylase deficiency by urinary metabolite ratios using gas chromatography-mass spectrometry analysis: Reference values for neonates and infants.
Kamrath C; Hartmann MF; Boettcher C; Zimmer KP; Wudy SA
J Steroid Biochem Mol Biol; 2016 Feb; 156():10-6. PubMed ID: 26493852
[TBL] [Abstract][Full Text] [Related]
23. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
[TBL] [Abstract][Full Text] [Related]
24. Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amniotic fluid.
Gueux B; Fiet J; Couillin P; Raux-Demay MC; Mornet E; Galons H; Villette JM; Boue J; Dreux C
J Clin Endocrinol Metab; 1988 Mar; 66(3):534-7. PubMed ID: 3258316
[TBL] [Abstract][Full Text] [Related]
25. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
[TBL] [Abstract][Full Text] [Related]
26. A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11-beta-hydroxylase deficiency in Campania region.
Valentino R; Tommaselli AP; Rossi R; Lombardi G; Varrone S
J Endocrinol Invest; 1990 Mar; 13(3):221-5. PubMed ID: 2365957
[TBL] [Abstract][Full Text] [Related]
27. Combined 21- and 11 beta-hydroxylase deficiency in familial congenital adrenal hyperplasia.
Hurwitz A; Brautbar C; Milwidsky A; Vecsei P; Milewicz A; Navot D; Rösler A
J Clin Endocrinol Metab; 1985 Apr; 60(4):631-8. PubMed ID: 2982904
[TBL] [Abstract][Full Text] [Related]
28. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
29. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
30. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
31. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
[TBL] [Abstract][Full Text] [Related]
32. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
[TBL] [Abstract][Full Text] [Related]
33. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 2. Analysis of steroids with high-performance liquid chromatography for diagnosis of congenital adrenal hyperplasia].
Mizushima Y; Fukushi M; Arai O; Takasugi N; Fujieda K; Matsuura N; Fujimoto S
Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):102-12. PubMed ID: 3494637
[TBL] [Abstract][Full Text] [Related]
34. Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone.
Koyama Y; Homma K; Fukami M; Miwa M; Ikeda K; Ogata T; Hasegawa T; Murata M
Clin Chem; 2012 Apr; 58(4):741-7. PubMed ID: 22273564
[TBL] [Abstract][Full Text] [Related]
35. [A case of congenital adrenogenital syndrome].
Sumiya H; Kawamura K; Kataumi Z; Fuse H; Ito H; Shimazaki J
Hinyokika Kiyo; 1985 Aug; 31(8):1433-9. PubMed ID: 3878668
[TBL] [Abstract][Full Text] [Related]
36. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
37. A chemiluminescent method for the measurement of pregnanetriol-3 alpha-glucuronide in human diluted urine.
Pinzani P; Magini A; Franceschetti F; Messeri G; Pazzagli M
J Biolumin Chemilumin; 1989 Jul; 4(1):580-6. PubMed ID: 2552757
[TBL] [Abstract][Full Text] [Related]
38. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
[TBL] [Abstract][Full Text] [Related]
39. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
40. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
Gong LF; Gao X; Yang N; Zhao JQ; Yang HH; Kong YY
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):253-258. PubMed ID: 30817302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
